Characterization of non-toxic mutant toxins of Vero toxin 1 that were constructed by replacing amino acids in the A subunit

Microbial Pathogenesis

Volumn 15, Issue 3, 1993, Pages 169-176

  Ohmura, Mari ^a   Yamasaki, Shinji ^a   Kurazono, Hisao ^a   Kashiwagi, Keiko ^b   Igarashi, Kazuei ^b   Takeda, Yoshifumi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Non toxic mutants; Site directed mutagenesis; Vero toxin 1 (VT1)

Indexed keywords

EID: 0027486751     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1993.1067     Document Type: Article

References (22)

1. Karmali MA, Infection by Verocytotoxin-producing Escherichia coti. Clin Microb Rev 1989; 2: 15-38.
2. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K, Site of action of a Vero toxin (VT2) from Escherichia coti 0157:H7 and of Shiga toxin on eukaryotic ribosomes. Eur J Biochem 1988; 171: 45-50.
3. Saxena SK, O'Brien AD, Ackerman EJ. Shiga toxin, Shige-like toxin II variant, and ricin are all singlesite RNA N-glycosidases of 28S rRNA when microinjected into Xenopus oocytes. J Biol Chem 1989; 264: 596-601.
4. Furutani M, Ito K, Oku Y, Takeda Y, Igarashi K, Demonstration of RNA N-glucosidase activity of a Vero toxin (VT2 variant) produced by Escherichia coli 091:H21 from a patient with the hemolytic uremic syndrome. Microbiol Immunol 1990; 34: 387-92.
5. Igarashi K, Ogasawara T, Ito K, Yutsudo T, Takeda Y. Inhibition of elongation factor 1 -dependent aminoacyl-tRNA binding to ribosomes by Shiga-1 ike toxin I (VT1) from Escherichia coli 01 57:H7 and by Shiga toxin. FEMS Microbiol Lett 1987; 44: 91-4.
6. Ogasawara T, Ito K, Igarashi K, Yutsudo T, Nakabayashi N, Takeda Y. Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli 0157:1-17 at the level of elongation factor-1 dependent aminoacyl-tRNA binding to ribosomes. Microb Pathogen 1988; 4: 127-35.
7. Endo Y, Mitsui K, Motizuki M, Tsurugi K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. J Biol Chem 1987; 262: 5908-12.
8. Endo Y, Tsurugi K. RNA N-glycosidase activity of ricin A-chain. J Biol Chem 1987; 262: 81 28-30.
9. Hovde CJ, Calderwood SB, Mekalanos JJ, Collier RJ. Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I. Proc Natl Acad Sci USA 1988; 85: 2568-72.
10. Jackson MP, Deresiewicz RL, Calderwood SB. Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits. J Bacteriol 1990; 172: 3346-50.
11. Yamasaki S, Furutani M, Ito K, Igarashi K, Nishibuchi M, Takeda Y. Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity. Microb Pathogen 1991; 11: 1-9.
12. Gordon VM, Whipp SC, Moon HW, O'Brien AD, Samuel JE. An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect Immun 1992; 60: 485-90.
13. Deresiewicz R, Calderwood SB, Robertus JD, Collier RJ. Mutations affecting the activity of the Shiga-like toxin I A-chain. Biochemistry 1992; 31: 3272-80.
14. Kunkel TA, Roberts JD, Zakour RA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Method Enzymol 1987; 154: 367-82.
15. Kurazono H, Sasakawa C, Yoshikawa M, Takeda Y. Cloning of a Vero toxin (VT1, Shiga-like toxin I) gene from a VT1 -converting phage isolated from Escherichia coli 0157: H7. FEMS Microbiol Lett 1987; 44: 23-26.
16. Takao T, Tanabe T, Hong Y-M, Shimonishi Y, Kurazono H, Yutsudo T, Sasakawa C, Yoshikawa M, Takeda Y. Identity of molecular structure of Shiga-like toxin I (VT1) from Escherichia coli 0157:H7 with that of Shiga toxin. Microb Pathogen 1988; 5: 357-69.
17. Sanger F, Nicklen S, Coulson R. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7.
18. Noda M, Yutsudo T, Nakabayashi N, Hirayama T, Takeda Y. Purification and some properties of Shiga-like toxin from Escherichia coli 0157:H7 that is immu no logically identical to Shiga toxin. Microb Pathogen 1987; 2: 339-49.
19. Oku Y, Yutsudo T, Hirayama T, O'Brien AD, Takeda Y. Purification and some proterties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shige-like toxin II (VT2). Microb Pathogen 1989; 6:113-22.
20. Yutsudo T, Honda T, Miwatani T, Takeda Y. Characterization of purified Shiga toxin from Shigella dysenteriae I. Microbiol Immunol 1986; 30: 1115-27.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
22. Oku Y, Uesaka Y, Hirayama T, Takeda Y. Development of a highly sensitive bead-ELISA to detect bacterial protein toxins. Microbiol Immunol 1988; 32: 807-16.